About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker ACRS

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Fhmls Xii, L.L.C.762,6630.5%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Fhmls Xii, L.P.762,6630.5%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Frazier Life Sciences XII, L.P.762,6630.5%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Fhmls Xi, L.L.C.86,9100.1%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Fhmls Xi, L.P.86,9100.1%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Frazier Life Sciences XI, L.P.86,9100.1%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Fhmlsp, L.L.C.7.88M5.4%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Fhmlsp, L.P.7.88M5.4%SCHEDULE 13G ↗
Sep 21, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Frazier Life Sciences Public Fund, L.P.7.88M5.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
RA Capital Healthcare Fund, L.P.12.72M9.1%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Rajeev Shah12.72M9.1%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Peter Kolchinsky12.72M9.1%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
RA Capital Management, L.P.12.72M9.1%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Vivo Opportunity Cayman, LLC700,2960.5%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Vivo Opportunity Cayman Fund, L.P.700,2960.5%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Vivo Opportunity, LLC5.97M4.3%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Vivo Opportunity Fund Holdings, L.P.5.97M4.3%SCHEDULE 13G/A ↗
Apr 27, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
BML Investment Partners, L.P.13.95M9.9%SCHEDULE 13G/A ↗
Apr 7, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
RA Capital Healthcare Fund, L.P.7.63M6.3%SCHEDULE 13G ↗
Apr 7, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Rajeev Shah7.63M6.3%SCHEDULE 13G ↗
Apr 7, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Peter Kolchinsky7.63M6.3%SCHEDULE 13G ↗
Apr 7, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
RA Capital Management, L.P.7.63M6.3%SCHEDULE 13G ↗
Mar 26, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
The Vanguard Group00.0%SCHEDULE 13G/A ↗
Mar 17, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
David Kroin9.35M7.0%SCHEDULE 13G ↗
Mar 17, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Deep Track Biotechnology Master Fund, Ltd.9.35M7.0%SCHEDULE 13G ↗
Mar 17, 2026SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Deep Track Capital, LP9.35M7.0%SCHEDULE 13G ↗
Feb 9, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
BML Investment Partners, L.P.14.25M11.9%SCHEDULE 13G/A ↗
Jan 21, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
BlackRock, Inc.6.70M6.2%SCHEDULE 13G/A ↗
Jan 9, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Bonita Biotech (HK) Ltd11.28M9.4%SCHEDULE 13G/A ↗
Jan 9, 2026SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Biosion, Inc.11.28M9.4%SCHEDULE 13G/A ↗
Nov 13, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Phillip Gross5.28M4.9%SCHEDULE 13G/A ↗
Nov 13, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Robert Atchinson5.28M4.9%SCHEDULE 13G/A ↗
Nov 13, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Adage Capital Management, L.P.5.28M4.9%SCHEDULE 13G/A ↗
Jul 29, 2025SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
The Vanguard Group6.66M6.2%SCHEDULE 13G ↗
Jul 24, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Israel A. Englander3.84M3.5%SCHEDULE 13G/A ↗
Jul 24, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Millennium Group Management LLC3.84M3.5%SCHEDULE 13G/A ↗
Jul 24, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Millennium Management LLC3.84M3.5%SCHEDULE 13G/A ↗
Jul 17, 2025SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
BlackRock, Inc.5.47M5.1%SCHEDULE 13G ↗
May 15, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Kris Jenner5.05M4.7%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Mark Bussard5.05M4.7%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Rock Springs Capital Master Fund LP00.0%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Rock Springs Capital LLC5.05M4.7%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Rock Springs Capital Management LP5.05M4.7%SCHEDULE 13G/A ↗
May 12, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Phillip Gross8.20M7.6%SCHEDULE 13G/A ↗
May 12, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Robert Atchinson8.20M7.6%SCHEDULE 13G/A ↗
May 12, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
Adage Capital Management, L.P.8.20M7.6%SCHEDULE 13G/A ↗
May 5, 2025SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Israel A. Englander5.54M5.1%SCHEDULE 13G ↗
May 5, 2025SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Millennium Group Management LLC5.54M5.1%SCHEDULE 13G ↗
May 5, 2025SCHEDULE 13GACRS
Aclaris Therapeutics, Inc.
Millennium Management LLC5.54M5.1%SCHEDULE 13G ↗
Apr 30, 2025SCHEDULE 13G/A (amended)ACRS
Aclaris Therapeutics, Inc.
The Vanguard Group4.97M4.6%SCHEDULE 13G/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:18 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances